• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清素在抗强迫药物作用及强迫症病理生理学中的不同作用。

Different roles for serotonin in anti-obsessional drug action and the pathophysiology of obsessive-compulsive disorder.

作者信息

Delgado P L, Moreno F A

机构信息

Department of Psychiatry, University of Arizona College of Medicine, Tucson 85274, USA.

出版信息

Br J Psychiatry Suppl. 1998(35):21-5.

PMID:9829023
Abstract

BACKGROUND

There is a major role for serotonin in the mechanism of anti-obsessional drug action. Drugs that block uptake of noradrenaline are not effective in the treatment of obsessive-compulsive disorder (OCD), while drugs that potently bock serotonin reuptake are effective. While enhancement of serotonin neurotransmission is clearly involved in the treatment of OCD, the role of serotonin in the pathophysiology of OCD is less clear.

METHOD

This paper provides a brief, focused review of the literature regarding treatment of OCD, the effects of drugs with selective action at various serotonin receptors and results of neurotransmitter depletion studies in patients with OCD.

RESULTS

Some patients with OCD may experience remission of OCD symptoms during intoxication with psychedelic drugs that have potent 5-HT2A/2C agonist activity. These findings, coupled with results from serotonin depletion studies in depressed and OCD patients, suggest that enhancement of serotonin neurotransmission may underlie both antidepressant and anti-obsessional drug action, although the targeted brain areas may differ.

CONCLUSIONS

OCD may not involve a dysfunction of the serotonin system. Rather, it is more likely to involve a dysfunction of specific brain circuits, particularly in the frontal cortex. Modulation of these circuits by serotonin neurons may underlie the specific action of anti-obsessional drugs.

摘要

背景

血清素在抗强迫药物作用机制中起主要作用。阻断去甲肾上腺素摄取的药物对强迫症(OCD)治疗无效,而强效阻断血清素再摄取的药物则有效。虽然血清素神经传递增强显然与强迫症治疗有关,但血清素在强迫症病理生理学中的作用尚不清楚。

方法

本文对有关强迫症治疗、对各种血清素受体具有选择性作用的药物的效果以及强迫症患者神经递质耗竭研究结果的文献进行了简要、重点突出的综述。

结果

一些强迫症患者在服用具有强效5-HT2A/2C激动剂活性的致幻药物中毒期间,强迫症症状可能会缓解。这些发现,再加上对抑郁症患者和强迫症患者进行的血清素耗竭研究结果,表明血清素神经传递增强可能是抗抑郁药和抗强迫药物作用的基础,尽管靶向的脑区可能不同。

结论

强迫症可能不涉及血清素系统功能障碍。相反,它更可能涉及特定脑回路功能障碍,特别是额叶皮质。血清素神经元对这些回路的调节可能是抗强迫药物特定作用的基础。

相似文献

1
Different roles for serotonin in anti-obsessional drug action and the pathophysiology of obsessive-compulsive disorder.血清素在抗强迫药物作用及强迫症病理生理学中的不同作用。
Br J Psychiatry Suppl. 1998(35):21-5.
2
Hallucinogens, serotonin and obsessive-compulsive disorder.致幻剂、血清素与强迫症
J Psychoactive Drugs. 1998 Oct-Dec;30(4):359-66. doi: 10.1080/02791072.1998.10399711.
3
[Pharmacological treatments for obsessive-compulsive disorder and the serotonin-dopamine hypothesis].[强迫症的药物治疗与血清素 - 多巴胺假说]
Seishin Shinkeigaku Zasshi. 2011;113(1):36-44.
4
Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice.眶额皮质 5-羟色胺 1B 受体在小鼠强迫行为样症状和 5-羟色胺再摄取抑制剂反应中的重要作用。
Biol Psychiatry. 2011 Dec 1;70(11):1039-48. doi: 10.1016/j.biopsych.2011.07.032. Epub 2011 Sep 13.
5
Pharmacologic therapy of obsessive compulsive disorder.强迫症的药物治疗
Adv Pharmacol. 1994;30:35-52. doi: 10.1016/s1054-3589(08)60171-4.
6
Obsessive-compulsive disorder-related disorders: the role of selective serotonergic reuptake inhibitors.与强迫症相关的障碍:选择性5-羟色胺再摄取抑制剂的作用
Int Clin Psychopharmacol. 1996 Dec;11 Suppl 5:75-87.
7
Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder.色氨酸耗竭对选择性 5-羟色胺再摄取抑制剂缓解的强迫症患者的影响。
J Psychopharmacol. 2017 Dec;31(12):1615-1623. doi: 10.1177/0269881117736916. Epub 2017 Nov 2.
8
A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.选择性5-羟色胺再摄取抑制剂治疗强迫症的疗效综述。
J Clin Psychiatry. 1999 Feb;60(2):101-6. doi: 10.4088/jcp.v60n0206.
9
Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder.强迫症当前及潜在药物疗法的作用机制。
Prog Neuropsychopharmacol Biol Psychiatry. 2006 May;30(3):362-73. doi: 10.1016/j.pnpbp.2005.11.005. Epub 2006 Jan 20.
10
Role of serotonin in obsessive-compulsive disorder.血清素在强迫症中的作用。
Br J Psychiatry Suppl. 1998(35):13-20.

引用本文的文献

1
Psychedelics for the Treatment of Obsessive-Compulsive Disorder: Efficacy and Proposed Mechanisms.用于治疗强迫症的迷幻剂:疗效及潜在机制
Int J Neuropsychopharmacol. 2024 Dec 1;27(12). doi: 10.1093/ijnp/pyae057.
2
Activation of serotonin 5-HT2A receptors inhibits high compulsive drinking on schedule-induced polydipsia.血清素5-HT2A受体的激活可抑制定时诱导性多饮中的高度强迫性饮水。
Psychopharmacology (Berl). 2015 Feb;232(4):683-97. doi: 10.1007/s00213-014-3699-7. Epub 2014 Aug 26.
3
Obsessive compulsive disorder.强迫症
BMJ Clin Evid. 2012 Jan 18;2012:1004.
4
Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD).选择性5-羟色胺再摄取抑制剂(SSRIs)与安慰剂治疗强迫症(OCD)的对比
Cochrane Database Syst Rev. 2008 Jan 23;2008(1):CD001765. doi: 10.1002/14651858.CD001765.pub3.